Please login to the form below

Not currently logged in


This page shows the latest leprosy news and features for those working in and with pharma, biotech and healthcare.

Novartis sets sights on eliminating leprosy

Novartis sets sights on eliminating leprosy

The new strategy focuses on interrupting leprosy transmission through early diagnosis and treatment, contact tracing of former patients, diagnostic tools and strict surveillance and response, according to Novartis. ... of the Novartis Foundation, which

Latest news

  • Novartis to expand SMS for Life approach across Africa Novartis to expand SMS for Life approach across Africa

    SMS for Life now reaches all 5, 000 public health facilities across Tanzania, where the programme has also added the tracking of medicines for tuberculosis and leprosy.

  • Medicine donations helping in battle against tropical diseases Medicine donations helping in battle against tropical diseases

    By 2020, the WHO anticipates leprosy, blinding trachoma, sleeping sickness (human African trypanosomiasis) and lymphatic filariasis to be eliminated worldwide, while rabies, chages disease, visceral leishmaniasis and schistosomiasis and

  • Navigating the minefield

    These include Mectizan for 'river blindness', Mycobutin for leprosy, Vibramycin for malaria and Capastat for tuberculosis.

  • Novartis extends WHO leprosy collaboration

    Novartis has announced it is to extend its collaboration with the World Health Organization to help end leprosy. ... Cases of leprosy have decreased 95 per cent over the past 20 years.

  • Who's afraid?

    For example, the Abbott Fund has trained 10, 500 health workers in HIV treatment in Tanzania, Novartis and the WHO have collaborated for the provision of free leprosy treatment and GSK

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....